Juyi Wen1, Hongliang Liu2, Lili Wang2, Xiaomeng Wang2, Ning Gu2, Zhensheng Liu2, Ting Xu3, Daniel R Gomez3, Ritsuko Komaki3, Zhongxing Liao3, Qingyi Wei4. 1. Department of Radiation Oncology, Navy General Hospital, Beijing, People's Republic of China; Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas. 2. Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina. 3. Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas. 4. Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina. Electronic address: qingyi.wei@duke.edu.
Abstract
INTRODUCTION: Autophagy not only plays an important role in the progression of cancer but is also involved in tissue inflammatory response. However, few published studies have investigated associations between functional genetic variants of autophagy-related genes and radiation pneumonitis (RP) as well as clinical outcomes in patients with NSCLC after definitive radiotherapy. METHODS: We genotyped nine potentially functional single-nucleotide polymorphisms (SNPs) in four autophagy-related genes (autophagy related 2B gene [ATG2B], autophagy related 10 gene [ATG10], autophagy related 12 gene [ATG12], and autophagy related 16 like 2 gene [ATG16L2]) in 393 North American patients with NSCLC treated by definitive radiotherapy and assessed their associations with RP, local recurrence-free survival (LRFS), progression-free survival (PFS), and overall survival (OS) in multivariable Cox proportional hazard regression analyses. RESULTS: We found that patients with the ATG16L2 rs10898880 CC variant genotype had a better LRFS, PFS, and OS (adjusted hazard ratio = 0.59, 0.64, and 0.64; 95% confidence interval: 0.45-0.79, 0.48-0.84, and 0.48-0.86; p = 0.0004, 0.002, and 0.003, respectively), but a greater risk for development of severe RP (adjusted hazard ratio = 1.80, 95% confidence interval: 1.04-3.12, p = 0.037) than did patients with AA/AC genotypes. Further functional analyses suggested that the ATG16L2 rs10898880 C variant allele modulated expression of the ATG16L2 gene. CONCLUSION: This is the first report that one potentially functional SNP rs10898880 in ATG16L2 may be a predictor of RP, LRFS, PFS, and OS in patients with NSCLC after definitive radiotherapy. Additional larger, prospective studies are needed to confirm these findings.
INTRODUCTION: Autophagy not only plays an important role in the progression of cancer but is also involved in tissue inflammatory response. However, few published studies have investigated associations between functional genetic variants of autophagy-related genes and radiation pneumonitis (RP) as well as clinical outcomes in patients with NSCLC after definitive radiotherapy. METHODS: We genotyped nine potentially functional single-nucleotide polymorphisms (SNPs) in four autophagy-related genes (autophagy related 2B gene [ATG2B], autophagy related 10 gene [ATG10], autophagy related 12 gene [ATG12], and autophagy related 16 like 2 gene [ATG16L2]) in 393 North American patients with NSCLC treated by definitive radiotherapy and assessed their associations with RP, local recurrence-free survival (LRFS), progression-free survival (PFS), and overall survival (OS) in multivariable Cox proportional hazard regression analyses. RESULTS: We found that patients with the ATG16L2rs10898880 CC variant genotype had a better LRFS, PFS, and OS (adjusted hazard ratio = 0.59, 0.64, and 0.64; 95% confidence interval: 0.45-0.79, 0.48-0.84, and 0.48-0.86; p = 0.0004, 0.002, and 0.003, respectively), but a greater risk for development of severe RP (adjusted hazard ratio = 1.80, 95% confidence interval: 1.04-3.12, p = 0.037) than did patients with AA/AC genotypes. Further functional analyses suggested that the ATG16L2rs10898880 C variant allele modulated expression of the ATG16L2 gene. CONCLUSION: This is the first report that one potentially functional SNP rs10898880 in ATG16L2 may be a predictor of RP, LRFS, PFS, and OS in patients with NSCLC after definitive radiotherapy. Additional larger, prospective studies are needed to confirm these findings.
Authors: Mi Ran Kang; Min Sung Kim; Ji Eun Oh; Yoo Ri Kim; Sang Yong Song; Sung Soo Kim; Chang Hyeok Ahn; Nam Jin Yoo; Sug Hyung Lee Journal: J Pathol Date: 2009-04 Impact factor: 7.996
Authors: Yenniffer Ávalos; Jimena Canales; Roberto Bravo-Sagua; Alfredo Criollo; Sergio Lavandero; Andrew F G Quest Journal: Biomed Res Int Date: 2014-09-18 Impact factor: 3.411
Authors: Alexander N Garcia; Nancy G Casanova; Daniel G Valera; Xiaoguang Sun; Jin H Song; Carrie L Kempf; Liliana Moreno-Vinasco; Kimberlie Burns; Tadeo Bermudez; Mia Valdez; Genesis Cuellar; Taylor Gregory; Radu C Oita; Vivian Reyes Hernon; Christy Barber; Sara M Camp; Diego Martin; Zhonglin Liu; Christian Bime; Saad Sammani; Anne E Cress; Joe Gn Garcia Journal: Transl Res Date: 2021-06-15 Impact factor: 7.012